In a patient with acute deep vein thrombosis on therapeutic heparin who now has hyperkalemia and mildly elevated creatinine, which medication should be discontinued: heparin, furosemide, lisinopril, or metformin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Should Be Stopped

In this patient with hyperkalemia (K 6.0 mEq/L) and acute kidney injury on heparin for DVT, lisinopril must be discontinued immediately as it is the primary cause of the hyperkalemia and is contraindicated in this clinical scenario.

Rationale for Stopping Lisinopril

The patient presents with two critical findings that mandate stopping the ACE inhibitor:

  • Hyperkalemia (K 6.0 mEq/L): The ACC/AHA guidelines explicitly state that aldosterone receptor antagonists and RAAS blockers should not be used when potassium is ≥5.0 mEq/L, and that inappropriate use when potassium >5.0 mEq/L is potentially harmful due to life-threatening hyperkalemia 1

  • Acute kidney injury with intercurrent illness: The Canadian Society of Nephrology recommends temporary discontinuation of RAAS blockers (including ACE inhibitors) in patients with serious intercurrent illness that increases the risk of AKI, particularly when GFR <60 mL/min/1.73 m² 1

  • Triple threat combination: This patient is likely on the dangerous combination of ACE inhibitor + diuretic (furosemide) + acute illness, which creates a "perfect storm" for acute kidney injury and hyperkalemia 2

Why Other Medications Should Continue

Heparin (Continue)

  • Essential for DVT treatment: Heparin is the cornerstone of acute DVT management and must be continued with dose adjustments to maintain therapeutic aPTT 3, 4
  • The prolonged PT/aPTT is expected with therapeutic heparin and does not indicate toxicity requiring discontinuation 1
  • Stopping heparin would expose the patient to high risk of thrombosis propagation and pulmonary embolism 3

Furosemide (Continue with caution)

  • Loop diuretics do not cause hyperkalemia; they actually promote potassium excretion 1
  • While the "sick-day rules" suggest temporary discontinuation of diuretics during acute illness 1, furosemide may be needed to manage volume status
  • The diuretic should be held only if the patient is volume depleted, but can be restarted once lisinopril is stopped

Metformin (Continue for now)

  • The patient's creatinine is 120 μmol/L (approximately 1.4 mg/dL), which corresponds to an eGFR likely >45 mL/min/1.73 m² 1
  • Canadian guidelines recommend metformin can be continued with GFR ≥45 mL/min/1.73 m² and should only be reviewed (not necessarily stopped) when GFR is 30-44 mL/min/1.73 m² 1
  • However, metformin should be temporarily held during this acute illness per "sick-day rules" and restarted once the patient is stable 1

Immediate Management Algorithm

  1. Stop lisinopril immediately - do not wait for potassium to normalize 1

  2. Treat hyperkalemia urgently with standard protocols (calcium gluconate if ECG changes, insulin/glucose, sodium polystyrene sulfonate)

  3. Continue heparin with aPTT monitoring to maintain therapeutic range of 1.5-2.5 times control 1

  4. Temporarily hold metformin during acute illness, restart when stable and eating normally 1

  5. Reassess furosemide - hold if volume depleted, continue if volume overloaded

  6. Monitor closely: Check potassium and creatinine daily until stable, then every 2-3 days 1

Common Pitfalls to Avoid

  • Do not restart lisinopril until potassium is <5.0 mEq/L and creatinine has returned to baseline 1
  • Do not stop heparin - the prolonged coagulation studies are expected and therapeutic 1
  • Do not assume the ACE inhibitor is "needed" for heart failure during acute illness - patient safety takes priority 1
  • Do not continue the triple combination of ACE inhibitor + diuretic + acute illness, as this dramatically increases AKI risk 2

The answer is C - Lisinopril must be stopped.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Daily NSAID Use in Stage 2 Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Current management of acute symptomatic deep vein thrombosis.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001

Research

Deep Vein Thrombosis.

Current treatment options in cardiovascular medicine, 1999

Related Questions

What is the next best step for an 84-year-old male with hypertension on lisinopril (angiotensin-converting enzyme inhibitor) 15 mg and hydrochlorothiazide (HCTZ) (thiazide diuretic) 12.5 mg, with a blood pressure averaging 150/80 mmHg, without causing hypotension, given that increasing lisinopril to 20 mg causes a drop in blood pressure to 104/60 mmHg and dizziness?
What additional medication can be added to lisinopril (Angiotensin-Converting Enzyme Inhibitor) 40 mg for an 85-year-old female with uncontrolled hypertension?
How can we better manage blood pressure in a diabetic patient with uncontrolled hypertension, currently on Lisinopril (Angiotensin-Converting Enzyme inhibitor), Hydrochlorothiazide (HCTZ) (Thiazide diuretic), and Amlodipine (Calcium channel blocker)?
Should I add lisinopril to the treatment regimen of a 71-year-old asymptomatic female patient with mildly elevated blood pressure on metoprolol?
What is the best management approach for a patient with impaired renal function who is taking lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) and experiencing a decline in renal function, as evidenced by hyperkalemia and elevated creatinine levels?
What is the appropriate workup and initial management for a 20‑year‑old male with intermittent dizziness and brief visual dimming on standing, normal examination, no gait disturbance, no tinnitus, and no cardiac history?
What neurobiological changes occur in the brain during negative symptoms of schizophrenia?
Can a woman of reproductive age taking tirzepatide (Mounjaro) use a combined oral contraceptive placed in an acid‑resistant (enteric‑coated) capsule?
Can high-dose zinc supplementation cause hypomagnesemia?
What is the appropriate amiodarone dosing for an adult with shock‑refractory ventricular tachycardia who is hypotensive?
What is the dosage equivalence between folic acid and dietary folate expressed in micrograms of Dietary Folate Equivalents (DFE)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.